Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Phreesia Inc

Healthcare US PHR

11.75USD
-0.31(2.57%)

Last update at 2026-03-10T20:00:00Z

Day Range

11.2812.33
LowHigh

52 Week Range

12.0540.00
LowHigh

Fundamentals

  • Previous Close 12.06
  • Market Cap1257.35M
  • Volume1555704
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-127.02000M
  • Revenue TTM337.88M
  • Revenue Per Share TTM6.28
  • Gross Profit TTM 171.64M
  • Diluted EPS TTM-2.68

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Type yearly yearly yearly yearly yearly
Date 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Income before tax -175.66300M -117.97900M -27.24300M -22.07300M -15.06201M
Minority interest - - - - 0.00000M
Net income -176.14600M -118.16100M -27.29200M -20.29300M -15.06201M
Selling general administrative 80.38M 68.67M 40.46M 30.46M 20.08M
Selling and marketing expenses 151.26M 106.42M 42.97M 32.36M 26.37M
Gross profit 171.64M 131.84M 96.29M 80.06M 62.89M
Reconciled depreciation 25.30M 21.30M 15.91M 13.92M 11.59M
Ebit -176.55200M -116.81700M -25.67100M -11.99100M -7.43609M
Ebitda -151.24800M -95.51500M -9.76300M 1.93M 4.16M
Depreciation and amortization 25.30M 21.30M 15.91M 13.92M 11.59M
Non operating income net other -0.17500M - 0.00100M - -
Operating income -176.55200M -116.81700M -25.67100M -11.99100M -9.49368M
Other operating expenses 457.46M 330.05M 174.35M 140.08M 109.38M
Interest expense 1.41M 1.16M -1.57300M -2.44500M 3.50M
Tax provision 0.48M 0.18M 0.05M -1.78000M 0.00000M
Interest income 1.06M 1.08M 1.57M 2.44M 3.50M
Net interest income 1.06M -1.08400M -1.57300M -2.44500M -3.50419M
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense 0.48M 0.18M 0.05M -1.78000M -2.06415M
Total revenue 280.91M 213.23M 148.68M 124.78M 99.89M
Total operating expenses 348.19M 248.66M 121.96M 95.36M 72.39M
Cost of revenue 109.27M 81.39M 52.39M 44.72M 37.00M
Total other income expense net 0.89M -1.16200M -1.57200M -10.08200M -2.06415M
Discontinued operations - - - - 0.00000M
Net income from continuing ops -176.14600M -118.16100M -27.29200M -20.29300M -15.06201M
Net income applicable to common shares -176.14600M -118.16100M -27.29200M -91.42300M -45.26100M
Preferred stock and other adjustments - - - - -
Breakdown 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Type yearly yearly yearly yearly yearly
Date 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Total assets 370.06M 494.48M 326.67M 158.76M 59.26M
Intangible assets 46.55M 30.41M 13.20M 9.93M 9.25M
Earning assets - - - - -
Other current assets 33.31M 30.63M 15.49M 12.37M 13.56M
Total liab 82.24M 77.20M 63.36M 56.89M 270.24M
Total stockholder equity 287.82M 417.28M 263.31M 101.86M -210.97390M
Deferred long term liab 2.68M 3.75M 1.25M 1.59M 2.06M
Other current liab 44.41M 39.72M 33.81M 21.61M 15.31M
Common stock 0.54M 0.52M 0.45M 0.37M 0.02M
Capital stock 0.54M 0.52M 0.45M 0.37M 0.02M
Retained earnings -606.08400M -429.93800M -311.77700M -284.48500M -210.99385M
Other liab 0.12M 0.07M - - 5.50M
Good will 33.74M 33.62M 8.31M 0.25M 0.25M
Other assets 5.09M 7.11M 3.58M 2.55M 2.23M
Cash 176.68M 313.81M 218.78M 90.31M 1.54M
Cash and equivalents 176.68M 313.81M 218.78M 90.31M 1.54M
Total current liabilities 79.04M 68.43M 54.99M 35.35M 27.93M
Current deferred revenue 17.69M 16.49M 10.84M 5.40M 6.49M
Net debt -167.50300M -298.01100M -204.46000M -66.45100M 30.74M
Short term debt 6.11M 7.10M 5.95M 2.32M 1.97M
Short long term debt 5.17M 5.82M 4.86M - 0.10M
Short long term debt total 9.18M 15.80M 14.32M 23.86M 32.29M
Other stockholder equity 893.36M 846.70M 574.63M 385.98M 27.86M
Property plant equipment 22.24M 36.98M 29.31M 14.49M 14.21M
Total current assets 262.44M 386.35M 272.27M 131.54M 32.88M
Long term investments - - - - 0.00000M
Net tangible assets 254.08M 353.24M 241.80M 91.68M -220.47700M
Short term investments - - - - 0.00000M
Net receivables 51.39M 40.26M 29.05M 21.98M 16.11M
Long term debt 2.73M 0.14M 6.47M 19.44M 27.92M
Inventory 1.06M 1.64M 8.95M 6.88M 1.67M
Accounts payable 10.84M 5.12M 4.39M 6.02M 4.16M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income - - - -158.75800M -27.86201M
Additional paid in capital - - - - 0.00000M
Common stock total equity 0.54M - 0.45M 0.37M 0.02M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity -606.08400M - -311.77700M - 0.00000M
Treasury stock -33.59600M -13.96000M -4.96500M -0.39900M 0.00000M
Accumulated amortization - - - - -
Non currrent assets other 5.01M 6.59M 1.67M 0.18M 2.67M
Deferred long term asset charges - - - - -
Non current assets total 107.62M 108.13M 54.40M 27.22M 26.38M
Capital lease obligations 1.28M 15.80M 2.99M 4.42M 4.27M
Long term debt total 2.73M 7.42M 6.47M 21.54M 30.32M
Breakdown 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Type yearly yearly yearly yearly yearly
Date 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Investments -26.20300M -65.22800M -25.08500M -12.32000M -11.02375M
Change to liabilities 7.49M 6.23M 1.56M -1.11700M 3.97M
Total cashflows from investing activities -26.20300M -65.22800M -25.08500M -12.32000M -11.02300M
Net borrowings -0.61300M -5.30600M -22.97500M -10.74000M 4.16M
Total cash from financing activities -20.80300M 234.97M 150.66M 100.27M 4.19M
Change to operating activities 1.24M -14.58400M 0.97M 1.27M -5.39300M
Net income -176.14600M -118.16100M -27.29200M -20.29300M -15.06201M
Change in cash -137.12900M 95.03M 128.47M 88.77M -8.96027M
Begin period cash flow 313.81M 218.78M 90.31M 1.54M 10.50M
End period cash flow 176.68M 313.81M 218.78M 90.31M 1.54M
Total cash from operating activities -90.12300M -74.71000M 2.89M 0.83M -2.12993M
Issuance of capital stock 0.00000M 245.81M 174.80M 130.78M 0.00000M
Depreciation 25.30M 21.30M 15.91M 13.92M 11.59M
Other cashflows from investing activities -21.47100M -34.42300M -6.51000M 0.00000M -1.19047M
Dividends paid - 0.00000M 0.00000M -14.95500M 14.96M
Change to inventory - - 2.62M 3.37M -2.44779M
Change to account receivables -11.13200M -10.21600M -6.61900M -5.90500M -3.80012M
Sale purchase of stock -19.38300M -8.99500M 174.22M 31.68M 0.36M
Other cashflows from financing activities 2.71M 2.42M -0.84600M -6.62900M 14.83M
Change to netincome 59.21M 38.22M 15.95M 10.52M 4.09M
Capital expenditures 26.20M 30.80M 18.57M 12.32M 9.83M
Change receivables -11.13200M - -6.61900M - -
Cash flows other operating 4.84M - 4.90M - -
Exchange rate changes - - - - -
Cash and cash equivalents changes -137.12900M - 128.47M - -
Change in working capital -3.86200M -18.57100M -4.09200M -5.75000M -3.54961M
Stock based compensation 58.77M 36.14M 13.49M 6.18M 1.45M
Other non cash items 5.37M 4.43M 4.94M 7.54M 1.38M
Free cash flow -116.32600M -105.51500M -15.68500M -11.49400M -11.96320M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PHR
Phreesia Inc		 -0.31 2.57% 11.75 - - 3.59 4.58 3.33 -9.9051
GEHC
GE HealthCare Technologies Inc.		 -2.9 3.83% 72.73 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A		 -5.88 3.01% 189.69 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 11.42 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 -0.07 1.34% 5.17 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

View All

Profile

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Wilmington, Delaware.

Phreesia Inc

434 Fayetteville Street, Raleigh, NC, United States, 27601

Key Executives

Name Title Year Born
Mr. Chaim Indig Co-Founder, CEO & Director 1979
Mr. Evan Roberts Co-Founder & COO 1980
Mr. Randy Rasmussen Chief Financial Officer 1980
Ms. Allison C. Hoffman Gen. Counsel & Sec. 1971
Mr. David Linetsky Sr. VP of Life Sciences 1979
Mr. Daniel Nathan Chief Technology Officer 1977
Mr. Balaji Gandhi Sr. VP of Investor Relations NA
Ms. Maureen McKinney VP of Corp. Communications NA
Ms. Amy Beth VanDuyn Sr. VP of HR 1974
Mr. Michael J. Davidoff Sr. VP of Payer Solutions 1973

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.